Terms: = Bone cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Diagnosis
11 results:
1. Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
Hamdi A; Cao K; Poon LM; Aung F; Kornblau S; Fernandez Vina MA; Champlin RE; Ciurea SO
Bone Marrow Transplant; 2015 Mar; 50(3):411-3. PubMed ID: 25621795
[TBL] [Abstract] [Full Text] [Related]
2. The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
Helgadottir H; Andersson E; Villabona L; Kanter L; van der Zanden H; Haasnoot GW; Seliger B; Bergfeldt K; Hansson J; Ragnarsson-Olding B; Kiessling R; Masucci GV
Cancer Immunol Immunother; 2009 Oct; 58(10):1599-608. PubMed ID: 19214504
[TBL] [Abstract] [Full Text] [Related]
3. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract] [Full Text] [Related]
4. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.
Deeg HJ; O'Donnell M; Tolar J; Agarwal R; Harris RE; Feig SA; Territo MC; Collins RH; McSweeney PA; Copelan EA; Khan SP; Woolfrey A; Storer B
Blood; 2006 Sep; 108(5):1485-91. PubMed ID: 16684959
[TBL] [Abstract] [Full Text] [Related]
5. Distant metastases in ovarian carcinoma.
Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
[TBL] [Abstract] [Full Text] [Related]
6. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
[TBL] [Abstract] [Full Text] [Related]
7. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807
[TBL] [Abstract] [Full Text] [Related]
8. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
[TBL] [Abstract] [Full Text] [Related]
9. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.
Remberger M; Svahn BM; Hentschke P; Löfgren C; Ringdén O
Bone Marrow Transplant; 1999 Oct; 24(8):823-30. PubMed ID: 10516691
[TBL] [Abstract] [Full Text] [Related]
10. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
[TBL] [Abstract] [Full Text] [Related]
11. Malignant fibrous histiocytoma tumor cells resemble fibroblasts.
Wood GS; Beckstead JH; Turner RR; Hendrickson MR; Kempson RL; Warnke RA
Am J Surg Pathol; 1986 May; 10(5):323-35. PubMed ID: 3010748
[TBL] [Abstract] [Full Text] [Related]